TELE Bio, Inc. Second Quarter Financial Results
TELA Bio, Inc. (TELA) announced a net loss of $0.51 per share for the second quarter, falling short of the Zacks consensus estimate of a $0.45 loss. This compares to a loss of $0.46 per share in the same period last year, with figures adjusted for non-recurring items.
Quarterly Earnings Performance
The company’s quarterly results reflect an earnings surprise of -13.33%. In the previous quarter, analysts expected a loss of $0.48 per share but the company reported a smaller loss of $0.23, resulting in a positive surprise of 52.08%. Over the past four quarters, TELA Bio has exceeded consensus EPS estimates twice.
Stock Movement and Future Outlook
The sustainability of the stock's short-term movement will largely depend on management’s commentary during the upcoming earnings call and future earnings outlook.
Year-to-Date Stock Performance
Since the start of the year, TELA Bio’s shares have declined approximately 38.7%, contrasting with the S&P 500's 12% gain.
Analyst Expectations and Industry Outlook
Looking ahead, investors are questioning the future trajectory of TELA Bi...